Items where authors include "Paul, C."

Article

Ring, J., Worm, M., Wollenberg, A. et al. (35 more authors) (2021) Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. Journal of the European Academy of Dermatology and Venereology, 35 (6). e362-e365. ISSN 0926-9959

Thyssen, J.P., Vestergaard, C., Barbarot, S. et al. (32 more authors) (2021) European Task Force on Atopic Dermatitis (ETFAD): position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics. Journal of the European Academy of Dermatology and Venereology, 35 (5). e308-e311. ISSN 0926-9959

Wollenberg, A., Christen‐Zäch, S., Taieb, A. et al. (24 more authors) (2020) ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. Journal of the European Academy of Dermatology and Venereology, 34 (12). pp. 2717-2744. ISSN 0926-9959

Wollenberg, A., Flohr, C., Simon, D. et al. (30 more authors) (2020) European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 34 (6). e241-e242. ISSN 0926-9959

Leshem, Y.A., Bissonnette, R., Paul, C. et al. (5 more authors) (2019) Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement. Journal of the European Academy of Dermatology and Venereology, 33 (5). pp. 807-815. ISSN 0926-9959

Luger, T., Boguniewicz, M., Carr, W. et al. (22 more authors) (2015) Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants. Pediatric Allergy and Immunology, 26 (4). pp. 306-315. ISSN 0905-6157